| __timestamp | Jazz Pharmaceuticals plc | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 85181000 | 7459000 |
| Thursday, January 1, 2015 | 135253000 | 11831000 |
| Friday, January 1, 2016 | 162297000 | 25705000 |
| Sunday, January 1, 2017 | 198442000 | 46181000 |
| Monday, January 1, 2018 | 226616000 | 59497000 |
| Tuesday, January 1, 2019 | 299726000 | 65003000 |
| Wednesday, January 1, 2020 | 335375000 | 74506000 |
| Friday, January 1, 2021 | 505748000 | 126006000 |
| Saturday, January 1, 2022 | 590453000 | 126215000 |
| Sunday, January 1, 2023 | 849658000 | 120161000 |
Infusing magic into the data realm
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Jazz Pharmaceuticals plc and Protagonist Therapeutics, Inc. have demonstrated contrasting yet intriguing R&D investment strategies.
From 2014 to 2023, Jazz Pharmaceuticals has consistently increased its R&D expenses, culminating in a staggering 900% growth. This strategic investment underscores their commitment to pioneering new treatments and maintaining a competitive edge.
Protagonist Therapeutics, while smaller in scale, has also shown a robust increase in R&D spending, with a 1,500% rise over the same period. This reflects their focused approach to developing niche therapies.
Both companies exemplify the critical role of R&D in driving biopharmaceutical advancements, each with its unique trajectory and impact.
Research and Development Investment: Novartis AG vs Jazz Pharmaceuticals plc
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
Research and Development Investment: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Protagonist Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending